About the Company
Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engages in finding treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $GNMX News
Plc Astrazeneca's Net Worth
This is based on reported shares across multiple companies, which include Viela Bio, Inc., Aevi Genomic Medicine, Inc., PhaseBio Pharmaceuticals Inc, Entasis Therapeutics Holdings Inc., ALBIREO ...
Genomic Medicine Market Forecasted to Expand at 17% CAGR by 2032
According to a recent report by Market.us, the Global Genomic Medicine Market size is expected to be worth around USD 123.9 Billion by 2032 from USD 31.4 Billion in 2023, growing at a CAGR of 17% ...
The Future of Precision Medicine: Leveraging Clinico-Genomic Data for Germline Disorders
During this discussion, experts will share methods for identifying promising drug targets and biomarkers by leveraging linked clinico-genomic data in advancing therapeutic development and its ...
Access to genomic medicine illustrates precision medicine’s delicate future
Japan – As genomics and precision medicine advances open new avenues for personalized treatments to replace the conventional one-size-fits-all model, who will actually benefit from them?
Bionano Genomics Inc BNGO
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Following cellular lineage
Kingsmore, Rady Children's Institute for Genomic Medicine; Katie Kennedy, BioSkryb Genomics Inc.; Martin W. Breuss, Department of Pediatrics, Section of Clinical Genetics and Metabolism ...
Do Physicians Think Genomic Medicine Will Be Useful for Patient Care?
However, the use of genomic information, so-called genomic medicine, in routine clinical care, has been slow in comparison to the growth in genomic discovery. The uptake of genomic technology into ...
OMIC Singular Genomics Systems, Inc.
Singular Genomics ... Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine.
Genomic Medicine: Evolving Science, Evolving Ethics
This process necessitated an uncommon understanding of genomic medicine including, but not limited to, knowledge of: ACMG/ASHG pediatric guidelines, the Genetic Information Nondiscrimination Act ...
Bumrungrad and BGI Partner to Advance Genomic Medicine
Assistant Professor Dr. Polakit Teekakirikul, Chief Scientific Officer (Multi-omics) at Bumrungrad Genomic Medicine Institute, added, "Bumrungrad has been at the forefront of genomics in the ...
Access to genomic medicine illustrates precision medicine's delicate future
As genomics and precision medicine advances open new avenues for personalized treatments to replace the conventional one-size-fits-all model, who will actually benefit from them? Paradigm shifts ...
Loading the latest forecasts...